Vulnerability in Bd Synapsys

CVE-2022-30277

BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).

Published · last modified .

CVSS v3 metric

CVSS v3 base score 5.7 (Medium). Vector: CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N.

EPSS exploit prediction

EPSS: 0.002 (12.3th percentile), scored .

Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 12th percentile — 12.3% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS trend (30 days)EPSS over the last 30 days for CVE-2022-30277: held from 0.002 to 0.002.

EPSS over last 30 days · oldest: 0.002 · newest: 0.002 · change: +0.000

Affected products

Weakness classification (CWE)

References

Frequently asked questions

What is CVE-2022-30277?
CVE-2022-30277 is a medium-severity vulnerability in Bd Synapsys, classified under Insufficient Session Expiration. CVSS score: 5.7/10. Published 2022-06-02.
How severe is CVE-2022-30277?
Medium severity. CVSS v3 base score is 5.7 out of 10.